CELLESTIA BIOTECH AG has a total of 11 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are GMT FINE CHEMICALS SA, MORPHIC THERAPEUTIC INC and BESHORE DOUGLAS C.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Hahn Uwe | 7 |
#2 | Bappert Erhard | 7 |
#3 | Bauer Michael | 7 |
#4 | Bold Guido | 2 |
#5 | Zoete Vincent | 2 |
#6 | Urech Charlotte | 2 |
#7 | Lehal Rajwinder | 2 |
#8 | Erhard Bappert | 1 |
#9 | Uwe Hahn | 1 |
#10 | Michael Bauer | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020208139A1 | Inhibitors of notch signalling pathway and use thereof in treatment of cancers | |
WO2020208138A1 | Compounds for the treatment of oncovirus induced cancer and methods of use thereof | |
EP3810574A1 | Process for making amino diaryl ethers and amino diaryl ethers hydrochloride salts |